Wolfe Research initiated coverage on Veracyte with a new price target
$VCYT
Medical Specialities
Health Care
Wolfe Research initiated coverage of Veracyte with a rating of Outperform and set a new price target of $50.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/20/2025 | $45.00 | Buy | Craig Hallum |
12/5/2024 | $38.00 → $37.00 | Buy → Neutral | Goldman |
11/15/2024 | $50.00 | Outperform | Wolfe Research |
10/16/2024 | $43.00 | Buy | UBS |
10/10/2024 | $40.00 | Buy | Guggenheim |
2/23/2024 | $30.00 → $33.00 | Buy | Needham |
1/18/2023 | Outperform → Mkt Perform | Raymond James | |
1/5/2023 | $33.00 | Sector Outperform | Scotiabank |